139 related articles for article (PubMed ID: 27386018)
21. p53 and MDM2 expression in odontogenic cysts and tumours.
Carvalhais J; Aguiar M; Araújo V; Araújo N; Gomez R
Oral Dis; 1999 Jul; 5(3):218-22. PubMed ID: 10483067
[TBL] [Abstract][Full Text] [Related]
22. [Quantitative study of the cellular nuclear DNA contents in odontogenic cysts and ameloblastoma].
Wang E; Yu G; Zhang Z; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):421-4. PubMed ID: 12641953
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD34 and maspin in ameloblastoma from a West African subpopulation.
Udeabor SE; Adisa AO; Kolude B; Barbeck M; Kirkpatrick CJ; Sader RA; Ghanaati S
Tumour Biol; 2014 Aug; 35(8):7727-31. PubMed ID: 24810924
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma.
Kondo S; Ota A; Ono T; Karnan S; Wahiduzzaman M; Hyodo T; Lutfur Rahman M; Ito K; Furuhashi A; Hayashi T; Konishi H; Tsuzuki S; Hosokawa Y; Kazaoka Y
Cancer Med; 2020 Apr; 9(8):2904-2917. PubMed ID: 32096304
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional profiles of SHH pathway genes in keratocystic odontogenic tumor and ameloblastoma.
Gurgel CA; Buim ME; Carvalho KC; Sales CB; Reis MG; de Souza RO; de Faro Valverde L; de Azevedo RA; Dos Santos JN; Soares FA; Ramos EA
J Oral Pathol Med; 2014 Sep; 43(8):619-26. PubMed ID: 24930892
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of interleukin-8 and activin A induces osteoclastogenesis in ameloblastoma.
Liu X; Chen Z; Lan T; Liang P; Tao Q
Int J Mol Med; 2019 Jun; 43(6):2329-2340. PubMed ID: 31017256
[TBL] [Abstract][Full Text] [Related]
27. Differential Profile of Primary and Recurrent Ameloblastomas Among Afro-descendants and Non-Afro-descendants-a Systematic Review.
Patel P; Effiom OA; Akinshipo AO; Akintoye SO
J Racial Ethn Health Disparities; 2024 Feb; 11(1):92-100. PubMed ID: 36596981
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Periostin expression in the pathogenesis of ameloblastoma.
Kang Y; Liu J; Zhang Y; Sun Y; Wang J; Huang B; Zhong M
Pathol Res Pract; 2018 Dec; 214(12):1959-1965. PubMed ID: 30196986
[TBL] [Abstract][Full Text] [Related]
29. Progress towards personalized medicine for ameloblastoma.
Gomes CC; Diniz MG; Gomez RS
J Pathol; 2014 Apr; 232(5):488-91. PubMed ID: 24749150
[TBL] [Abstract][Full Text] [Related]
30. Monosomy 22 and del(10)(p12) in an ameloblastoma previously diagnosed as an adenoid cystic carcinoma of the salivary gland.
Barril N; Oliveira PR; Tajara EH
Cancer Genet Cytogenet; 1996 Oct; 91(1):74-6. PubMed ID: 8908172
[TBL] [Abstract][Full Text] [Related]
31. Tuftelin mRNA is expressed in a human ameloblastoma tumor.
Deutsch D; Fermon E; Lustmann J; Dafni L; Mao Z; Leytin V; Palmon A
Connect Tissue Res; 1998; 39(1-3):177-84; discussion 187-94. PubMed ID: 11062999
[TBL] [Abstract][Full Text] [Related]
32. Ameloblastoma with mucous cells: A clinicopathological, BRAF mutation, and MAML2 rearrangement study.
Xia RH; Zhang CY; Sun JJ; Tian Z; Hu YH; Gu T; Wang LZ; Li J
Oral Dis; 2020 May; 26(4):805-814. PubMed ID: 31954088
[TBL] [Abstract][Full Text] [Related]
33. Biological profile of ameloblastoma and its location in the jaw in 1246 Nigerians.
Agbaje JO; Olumuyiwa Adisa A; Ivanova Petrova M; Adenike Olusanya A; Osayomi T; Ajibola Effiom O; Oladele Soyele O; Gbenga Omitola O; Babajide Olawuyi A; Obos Okiti R; Eziafa Saiki T; Fomete B; Aremu Ibikunle A; Okwuosa C; Abimbola Olajide M; Mofoluwake Ladeji A; Emmanuel Adebiyi K; Mobola Emmanuel M; Sikiru Lawal H; Uwadia E; Oludare Fakuade B; Mohammed Abdullahi Y; Politis C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Nov; 126(5):424-431. PubMed ID: 30126803
[TBL] [Abstract][Full Text] [Related]
34. Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts.
Zedan W; Robinson PA; Markham AF; High AS
J Pathol; 2001 Aug; 194(4):473-7. PubMed ID: 11523056
[TBL] [Abstract][Full Text] [Related]
35. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
[TBL] [Abstract][Full Text] [Related]
36. [Research advances in the v-raf murine sarcoma viral oncogene homolog gene mutation in ameloblastoma].
Yan XC; Sun LS; Dong ZW; You Z; Dong Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Jul; 53(7):500-502. PubMed ID: 29996373
[TBL] [Abstract][Full Text] [Related]
37. In reply to "Comment on: F. Sandra et al., The role of MDM2 in the proliferative activity of ameloblastoma", Oral Oncology 2002;38(2):153-7.
Sandra F
Oral Oncol; 2003 Oct; 39(7):745. PubMed ID: 12907216
[No Abstract] [Full Text] [Related]
38. Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.
Ida-Yonemochi H; Ahsan MS; Saku T
Histopathology; 2011 Jan; 58(2):234-45. PubMed ID: 21255062
[TBL] [Abstract][Full Text] [Related]
39. Altered patterns of MDM2 and TP53 expression in human bladder cancer.
Lianes P; Orlow I; Zhang ZF; Oliva MR; Sarkis AS; Reuter VE; Cordon-Cardo C
J Natl Cancer Inst; 1994 Sep; 86(17):1325-30. PubMed ID: 8064890
[TBL] [Abstract][Full Text] [Related]
40. Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation.
Fernandes GS; Girardi DM; Bernardes JPG; Fonseca FP; Fregnani ER
BMC Cancer; 2018 Sep; 18(1):887. PubMed ID: 30208863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
